WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using ...

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...

The Department of Health and Human Services said it is canceling nearly half a billion dollars in mRNA vaccine contracts, ...

The federal government is calling off around $500 million worth of vaccine development projects that use mRNA technology, ...